CD274 and neoplasm: Compared with other studies, the lower rate of the PD-L1 tumor cell expression in this study and the reported rate of high variability in previous studies could be attributed to the use of different anti-PD-L1 antibodies, different cutoff values, and tumor heterogeneity.